- SBC-110736
-
- $48.00 / 1mg
-
2024-11-19
- CAS:1629166-02-4
- Min. Order:
- Purity: 99.76%
- Supply Ability: 10g
|
| SBC110,736 Basic information |
Product Name: | SBC110,736 | Synonyms: | SBC110,736;SBC-1107326;N-(4-{[4-(4-Methylphenyl)-2-phenyl-1-piperazinyl]carbonyl}phenyl)acetamid;SBC110736;SBC 110736;Acetamide, N-[4-[[4-(4-methylphenyl)-2-phenyl-1-piperazinyl]carbonyl]phenyl]-;SBC-1107326(b);cholesterol,inhibit,Ser/Thr Protease,diet,Serine endopeptidases,Inhibitor,Threonine proteases,SBC 110736,SBC-110736,high,fat,Serine proteases;N-(4-(2-Phenyl-4-(p-tolyl)piperazine-1-carbonyl)phenyl)acetamide | CAS: | 1629166-02-4 | MF: | C26H27N3O2 | MW: | 413.51 | EINECS: | | Product Categories: | | Mol File: | 1629166-02-4.mol |  |
| SBC110,736 Chemical Properties |
Boiling point | 681.1±55.0 °C(Predicted) | density | 1.204±0.06 g/cm3(Predicted) | storage temp. | Store at -20°C | solubility | Soluble in DMSO:64.0(Max Conc. mg/mL);154.77(Max Conc. mM) | form | A crystalline solid | pka | 14.77±0.70(Predicted) | color | White to off-white |
| SBC110,736 Usage And Synthesis |
Uses | SBC-110736 is a proprotein convertase subtilisin kexin type 9 (PCSK9) inhibitor extracted from patent WO2014150395A1[1]. | in vivo | SBC-110736 (male C57BL/6 mice) lowers cholesterol levels in mice that were fed high fat diet, showing a mean of 38% reduction in total cholesterol levels after two weeks relative to high fat diet animal levels and a mean 50% reduction toward return to regular diet cholesterol levels[1]. | References | [1] Sherin Salaheldin Abdel-Meguid, et al. Anti-pcsk9 compounds and methods for the treatment and/or prevention of cardiovascular diseases. WO2014150395A1. |
| SBC110,736 Preparation Products And Raw materials |
|